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DERMATOLOGIC SURGERY
Fibrous hamartoma of infancy: An Italian
multi-institutional experience
Elena Carretto, MD,a Patrizia Dall’Igna, MD,a Rita Alaggio, MD,b Fortunato Siracusa, MD,c
Claudio Granata, MD,d Andrea Ferrari, MD,e and Giovanni Cecchetto, MDa
Padua, Palermo, Genoa, and Milan, Italy
Background: Fibrous hamartoma (FH) of infancy is a benign mesenchymal tumor, occurring as a
superficial mass. Complete excision is curative.
Objective and Methods: The clinical features and treatment results of 18 children with FH are described.
Results: Local excision was the most common procedure. Surgery was radical in 10 patients, with
microscopic residual disease in 6; all of them are alive with no evidence of disease 2 to 49 months after
diagnosis. One patient, treated with a local reexcision for macroscopic residual disease (and chemotherapy
for a synchronous desmoid fibromatosis) is well 83 months after diagnosis; the last patient, with a lesion of
the labia majora, only underwent biopsy and is doing well, awaiting plastic surgery.
Limitations: The results did not reach statistical significance due to difficulties in collecting cases.
Conclusions: FH should be treated by complete excision; in our experience a nonradical excision was also
able to achieve the cure. An aggressive approach should be avoided, as the overall prognosis is excellent.
( J Am Acad Dermatol 2006;54:800-3.)F
ibrous hamartoma (FH) of infancy is a mesen-
chymal tumor of myofibroblastic derivation;
it was first described by Reye1 in 1956 as a
subdermal fibromatous tumor of infancy and by
Enzinger2 in 1965 as ‘‘fibrous hamartoma of infancy.’’
It is an uncommon, benign, subcutaneous fibrous
proliferation, usually detected during the first 2 years
of life. Approximately 15% to 20% of FH cases are
present at birth.3 Male infants are more frequently
affected than female infants. FH is usually solitary;
limbs, trunk, the sacral region, and scrotum are the
most common sites. The lesion is characterized by
rapid initial growth,4 but generally it does not cause
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doi:10.1016/j.jaad.2005.11.1076800any symptoms. The clinical and radiologic features
are quite similar to those of malignant soft tissue
sarcomas, and the definitive diagnosis may be
achieved only by histologic evaluation. Complete
local excision is curative and the recurrence rate is
less than 15%.
We evaluated a group of patients whose data
were collected from 6 centers of pediatric surgery
and pediatric oncology, with the aim of obtaining
information on their tumor characteristics, treatment,
and outcome.
PATIENTS AND METHODS
The patients were 14 male and 4 female children,
whose age at the time when the lesion was first
noticed ranged from birth to 11 years (median, 12.5
months). All the FH cases were solitary; they were
located on limbs (9 patients), sacral region (2),
scrotum (2), trunk (3), head and neck (1), and vulva
(1). Seventeen children were healthy at the moment
of diagnosis, whereas one patient was affected by
desmoid fibromatosis of the hand. The clinical fea-
tures of the patients as well as treatment results are
summarized in Table I.
The lesion was characterized by rapid initial
growth, and its appearance was that of a solid mass,
strictly adherent to subcutaneous tissue. The size
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Patient
no. Sex Site
Time
between
onset and
treatment FNAB
Size
(cm)
Presence
of
capsule
Age at
surgery
(mo)
Type of
surgery LR
Further
treatments Outcome
FU
(mo)
1 M Trunk No 14 Radical No No RC (18)
2 F Sacral
region
No 16 Radical No No RC (18)
3 M R arm 2 y No 2.5 3
2.5 3
1.2
Yes 32 Radical No No RC (18) 38
4 M R
hemiscrotum
1 y No 3.5 3 3.5 Yes 26 Radical
(partial
right
hemiscro-
tectomy)
Yes
(after
12 mo)
Excision
of residual
scrotum
RC (28) 66
5 F L arm 20 days No 3.5 3
1.5 3
2.5
Yes 8 Radical Yes
(after
18 mo)
Reexcision RC (28) 115
6 M L leg 1 y No 3 121 Microscopic
residual
No No RC (18) 49
7 M Sacral
region
1 day No 5.5 3 3 No Birth Radical No No RC (18) 79
8 M H-N No 4 3 3 No 52 Radical No No RC (18) 118
9 M L arm No 7 3 3 6 Microscopic
residual
Yes
(after
2 mo)
Reexcision
with
microscopic
residual
RC (28) 2
10 M L arm 3 mo Yes 4.5 3 2.5 11 Microscopic
residual
No No RC (18) 4
11 M L arm No 17 Radical No No RC (18)
12 F Labia
majora
No 136 Macroscopic
residual
(biopsy)
Yes No AWD 38
13 M R arm No No 9 Microscopic
residual
No No RC (18) 33
14 M L
hemiscrotum
8 mo No 2 No 9 Radical (left
hemiscro-
tectomy)
No No RC (18) 92
15 M Trunk 4 mo No 2.5 3 1.5 No 24 Macroscopic
residual
Yes
(after
3 mo)
Reexcision
and CT
AWD 83
16 M L arm 1 mo Yes 2.4 3
1.6 3 1
No 8 Microscopic
residual
No No RC (18) 4
17 F R arm No 4 Radical No No RC (18)
18 M Trunk 5 mo No 3.0 3
1.8 3 1
11 Microscopic
residual
No No RC (18)
AWD, alive with disease; CT, chemotherapy; FNAB, fine-needle aspiration biopsy; FU, follow-up; H-N, head and neck; L, left; LR, local relapse;
L, left. R. right; RC (18), first complete remission; RC (28), second complete remission.ranged between 2 and 7 cm, and in none of the cases
was there a tendency to spontaneously regress.
Clinical examination showed a tender, nonpain-
ful mass, sometimes difficult to distinguish from
deeper fascial tissues. Overhanging skin was normal.
Ultrasonography showed that the mass was charac-
terized by undefined margins and a heterogeneous
echogenicity.Noother radiologic investigationswere
considered useful.In 2 patients diagnosis was obtained by a fine-
needle aspiration biopsy: the examination yielded
moderate cellularity, loosely lying and clustered
fibroblastic-appearing cells, fatty tissue, and collag-
enous material without evidence of significant nu-
clear atypia or mitoses. All histologic specimens
were reviewed by the national panel for soft tissue
sarcomas. Hematoxylin-eosinestained sectionswere
reevaluated and a complete immunohistochemical
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RESULTS
All patients underwent surgery. The operation
was complete in 10 patients; two of them, one of
whom had a local relapse after 12 months and the
other after 18 months, underwent local reexcision,
and radicality was achieved. All the patients subse-
quently maintained complete remission with a fol-
low-up period of 38 to 118 months (median, 85.5
months) from diagnosis. In 6 cases the resection was
macroscopically radical but microscopic residuals
were found at histologic examination; one patient
underwent a reexcision after 2 months because of
local relapse, without achieving radicality. No re-
lapse was observed either in this or in the other 5
cases at follow-up (range, 2-49 months; median, 4
months). In one patient, who was also affected by
desmoid fibromatosis of the right hand, macroscopic
residuals were left after the first surgical operation on
an FH of the trunk; the patient was treated 3 months
later with a local reexcision (which left microscopic
residual disease); he also had chemotherapy (vin-
cristine, doxorubicin [Adriamycin], dactinomycin,
cyclophosphamide, and methotrexate) for the des-
moid fibromatosis; he is alive with disease 83 months
after diagnosis. Finally, a large biopsywas performed
in one girl with a lesion in the labia majora. At
Fig 1. A and B, Case 16. Clinical appearance of FH.present the patient has stable disease and is waiting
for definitive plastic surgery (follow-up, 38 months).
The histologic examinations demonstrated a
typical organoid lesion, with a mixture of fat, mature
myofibroblasts arranged in fascicles, and immature
mesenchymal cells, sometimes forming highly cellu-
lar nodules. The proportion of the single compo-
nents was variable in the different cases, generally
with a predominance of fat and myofibroblasts. The
diagnosis was generally not difficult with hematox-
ylin-eosin staining, in the cases in which a wide
surgical biopsywas provided. In one case, a previous
diagnosis of fibromatosis was given; the biopsy
specimen was small, represented only by a myofi-
broblastic component with an infiltrative growth
pattern in the fat tissue at the periphery. The histo-
logic examination of the additional surgical speci-
men showed the typical triphasic pattern of FH. In all
cases a focal positivity for smooth muscle actin was
demonstrated at immunohistochemistry. Desmin
and S-100 stains were consistently negative.
DISCUSSION
FH of infancy is an uncommon benign lesion
with a characteristic histologic appearance; it usually
occurs as a small, rapidly growing, superficial soft
tissue swelling, developing in the first 2 years of life.
The majority of our patients were infants, as de-
scribed in the literature. The affected children are
generally healthy and association with other neo-
plasms or congenital malformations has not been
reported.5 Although the shoulder girdle area and
upper arm are the favored locations, FH may occur
anywhere in the body.6-8 The most common site of
the lesion in our series, as in others5,9 was the upper
arm (Fig 1). Most of the lesions are usually small,
although masses as large as 10 cm have been
Fig 2. Case 16. Histologic appearance of hamartoma.
Typical organoid pattern with adipose component, dis-
secting striated muscle, and fibroblastic proliferation in
fascicles. (Hematoxylin-eosin stain; original magnification:
380.)
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one case showed multiple coarse hair over the
surface of the lesion, which had been previously
unreported.11
Ultrasonography reveals a mixed echogenicity
that may be suggestive of hemangioma, lymphangi-
oma, or lipoma. Generally no other radiologic in-
vestigations are recommended.8
The main diagnostic problem for these lesions
concerns the differential diagnosis with other soft
tissue masses, which require a different clinical and
therapeutic approach. Fine-needle aspiration biopsy
may be an useful tool in recognizing the myofibro-
blastic nature of the lesion,12 but only histology can
disclose the typical organoid pattern that is a clue
to the diagnosis, together with the immature mesen-
chymal component (Fig 2). The most important
differential diagnosis is represented by infantile
fibromatosis, a locally aggressive lesion, character-
ized by a myofibroblastic proliferation, sometimes
with features of immaturity and devoid of the
organoid pattern.
The treatment of choice for FH of infancy is local
excision2,3,13,14 with an envelope of normal tissue
because of its deep spread and occasional presence
of nearby lesions. The rationale for surgery is the
progressive growth of this lesion and the necessity
to obtain a diagnosis. FH can mimic a soft-tissue
sarcoma, and diagnosis might be misinterpreted
when the typical organoid and triphasic patterns
are not recognized in the small fragments of tissue
obtained through a single biopsy.
A radical excision is mandatory to avoid local
relapses, which may occur in 12% to 15% of cases,
generally within a few months after primary surgery.
However, since FH is a benign lesion, minimal
residual disease may be accepted in those cases in
which complete surgery would imply serious ana-
tomic and functional impairment for the patient.
In our series 2 of 10 patients had a local relapse 12
and 18 months after primary surgery, despite the
initial radical excision. On the other hand, 5 of 6
patients with microscopic residuals after the first
operation suffered no relapse.In conclusion, even if a subcutaneous solid,
tender mass in a child usually suggests a malignant
tumor, physicians need to be aware of the existence
of some benign conditions, such as FH of infancy.
Diagnosis is easily made because of its characteristic
histologic features. FH of infancy should be treated
by a local, complete excision. Since recurrence is
rare and the overall prognosis is excellent, aggres-
sive, mutilating procedures are discouraged, and
repeated, nondestructive resections should be per-
formed. If a conservative re-excision of an FH is not
feasible, a strict ‘‘wait and see’’ strategy should be
preferred.
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